CAL-4

N/A

Report date: 2025/06/11 10:26:01
NME

Base Information

Drug NameCAL-4
Drug Alias NameCAL-X
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationHypersensitivityPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalyxha Biotechnologies Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesCalyxha Biotechnologies Gmbh
Inactive CompaniesN/A
Active IndicationsNerve DegenerationHypersensitivityPulmonary Disease, Chronic Obstructive +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A